Home>
US Stocks>
Collplant Biotechnologies

Collplant Biotechnologies share price today

(CLGN)

Collplant Biotechnologies share price is $3.93 & -₹3.93 as on 12 Dec 2024, 2.30 'hrs' IST

$3.93

▲

0.02

(0.51%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Collplant Biotechnologies share price in Dollar and Rupees. Guide to invest in Collplant Biotechnologies from India. Also see the sentimental analysis on Indian investors investing in Collplant Biotechnologies. Get details on the Indian mutual funds that are investing in Collplant Biotechnologies. Get Analyst recommendations and forecasts along with all the Collplant Biotechnologies's financials.

Collplant Biotechnologies share price movements

$3.85
$4.10
$3.93
2.04%
Downside
Day's Volatility :6.1%
Upside
4.15%
$3.31
$6.99
$3.93
15.78%
Downside
52 Weeks Volatility :52.65%
Upside
43.78%

Collplant Biotechnologies Returns

Period	Collplant Biotechnologies Ltd	Index (Russel 2000)
3 Months	-18.63%	0.0%
6 Months	-21.4%	0.0%
1 Year	-20.93%	0.0%
3 Years	-71.42%	-20.0%

Collplant Biotechnologies Key Statistics

in dollars & INR

Previous Close	$3.91
Open	$3.85
Today's High	$4.1
Today's Low	$3.85
Market Capitalization	$44.8M
Today's Volume	$6.6K
52 Week High	$6.99
52 Week Low	$3.31
Revenue TTM	$689.0K
EBITDA	$-17.3M
Earnings Per Share (EPS)	$-1.53
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-61.55%

How to invest in Collplant Biotechnologies from India?

It is very easy for Indian residents to invest directly in Collplant Biotechnologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Collplant Biotechnologies stock in both rupees (INR) and dollars (USD). Search for Collplant Biotechnologies or CLGN on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Collplant Biotechnologies or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Collplant Biotechnologies shares which would translate to -0.003 fractional shares of Collplant Biotechnologies as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Collplant Biotechnologies

183%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Collplant Biotechnologies on INDmoney from India has grown in the last 30 days as on Dec 12, 2024. 183% more investors are searching Collplant Biotechnologies in the last 30 days versus the previous period.

Global Institutional Holdings in Collplant Biotechnologies

Parallel Advisors, LLC
0.03%

Analyst Recommendation on Collplant Biotechnologies

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Collplant Biotechnologies(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Collplant Biotechnologies

What analysts predicted

Upside of 218.07%

Current:

$3.93

Target:

$12.50

Insights on Collplant Biotechnologies

Price Movement
In the last 1 month, CLGN stock has moved down by -10.9%
Decreasing Revenue
Revenue is down for the last 2 quarters, 249.0K → 4.0K (in $), with an average decrease of 98.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -4.19M → -4.32M (in $), with an average decrease of 1.6% per quarter
CLGN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 46.2% return, outperforming this stock by 67.6%
CLGN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 46.4% return, outperforming this stock by 122.6%
Price to Sales
ForCLGN every $1 of sales, investors are willing to pay $65.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $15.4 for every $1 of sales.

Collplant Biotechnologies Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$4.8M	↑ 897.75%
Net Income	$-6.2M	↑ 3.27%
Net Profit Margin	-130.5%	↑ 1130.34%

	FY19	Y/Y Change
Revenue	$2.3M	↓ 51.59%
Net Income	$-14.7M	↑ 135.19%
Net Profit Margin	-634.04%	↓ 503.54%

	FY20	Y/Y Change
Revenue	$6.1M	↑ 164.75%
Net Income	$-5.8M	↓ 60.48%
Net Profit Margin	-94.64%	↑ 539.4%

	FY21	Y/Y Change
Revenue	$15.6M	↑ 154.86%
Net Income	$409.0K	↓ 107.04%
Net Profit Margin	2.61%	↑ 97.25%

	FY22	Y/Y Change
Revenue	$299.0K	↓ 98.09%
Net Income	$-16.8M	↓ 4196.09%
Net Profit Margin	-5.6K%	↓ 5605.62%

	FY23	Y/Y Change
Revenue	$11.0M	↑ 3565.22%
Net Income	$-7.0M	↓ 58.1%
Net Profit Margin	-64.05%	↑ 5538.96%

	Q2 FY23	Q/Q Change
Revenue	$10.2M	↑ 2251.96%
Net Income	$5.8M	↓ 247.33%
Net Profit Margin	56.58%	↑ 959.81%

	Q3 FY23	Q/Q Change
Revenue	$43.0K	↓ 99.58%
Net Income	$-4.4M	↓ 175.96%
Net Profit Margin	-10.2K%	↓ 10235.65%

	Q4 FY23	Q/Q Change
Revenue	$299.0K	↑ 595.35%
Net Income	$-4.7M	↑ 7.13%
Net Profit Margin	-1.6K%	↑ 8610.84%

	Q1 FY24	Q/Q Change
Revenue	$98.0K	↓ 67.22%
Net Income	$-4.2M	↓ 10.54%
Net Profit Margin	-4.3K%	↓ 2712.38%

	Q2 FY24	Q/Q Change
Revenue	$249.0K	↑ 154.08%
Net Income	$-4.2M	↑ 0.36%
Net Profit Margin	-1.7K%	↑ 2589.85%

	Q3 FY24	Q/Q Change
Revenue	$4.0K	↓ 98.39%
Net Income	$-4.3M	↑ 2.76%
Net Profit Margin	-108.2K%	↓ 106459.24%

	FY18	Y/Y Change
Total Assets	$9.0M	↑ 12.15%
Total Liabilities	$4.3M	↓ 21.37%

	FY19	Y/Y Change
Total Assets	$10.8M	↑ 18.81%
Total Liabilities	$6.7M	↑ 55.35%

	FY20	Y/Y Change
Total Assets	$10.8M	↑ 0.83%
Total Liabilities	$6.4M	↓ 4.5%

	FY21	Y/Y Change
Total Assets	$51.2M	↑ 372.5%
Total Liabilities	$6.1M	↓ 4.1%

	FY22	Y/Y Change
Total Assets	$37.8M	↓ 26.27%
Total Liabilities	$5.5M	↓ 10.09%

	FY23	Y/Y Change
Total Assets	$34.1M	↓ 9.64%
Total Liabilities	$5.8M	↑ 5.45%

	Q2 FY23	Q/Q Change
Total Assets	$41.6M	↑ 16.25%
Total Liabilities	$5.5M	↓ 5.78%

	Q3 FY23	Q/Q Change
Total Assets	$37.6M	↓ 9.65%
Total Liabilities	$5.2M	↓ 6.69%

	Q4 FY23	Q/Q Change
Total Assets	$34.1M	↓ 9.14%
Total Liabilities	$5.8M	↑ 12.13%

	Q1 FY24	Q/Q Change
Total Assets	$30.3M	↓ 11.23%
Total Liabilities	$5.8M	↑ 1.04%

	Q2 FY24	Q/Q Change
Total Assets	$26.6M	↓ 12.3%
Total Liabilities	$5.8M	↓ 0.15%

	Q3 FY24	Q/Q Change
Total Assets	$22.4M	↓ 15.52%
Total Liabilities	$5.5M	↓ 5.36%

	FY18	Y/Y Change
Operating Cash Flow	$-1.2M	↓ 75.93%
Investing Cash Flow	$-832.0K	↑ 555.12%
Financing Cash Flow	$2.6M	↓ 71.76%

	FY19	Y/Y Change
Operating Cash Flow	$-5.7M	↑ 360.42%
Investing Cash Flow	$-1.5M	↑ 75.6%
Financing Cash Flow	$5.4M	↑ 105.5%

	FY20	Y/Y Change
Operating Cash Flow	$-4.5M	↓ 21.95%
Investing Cash Flow	$-519.0K	↓ 64.48%
Financing Cash Flow	$4.5M	↓ 17.47%

	FY21	Y/Y Change
Operating Cash Flow	$2.5M	↓ 156.19%
Investing Cash Flow	$-31.6M	↑ 5980.15%
Financing Cash Flow	$38.8M	↑ 768.09%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.7M	↑ 8.52%
Investing Cash Flow	$-396.0K	↑ 0.0%
Financing Cash Flow	$89.0K	↓ 88.92%

Collplant Biotechnologies Technicals Summary

Sell

Neutral

Buy

Collplant Biotechnologies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Collplant Biotechnologies Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Collplant Biotechnologies Ltd	-10.88%	-21.4%	-20.93%	-71.42%	-28.55%
Regeneron Pharmaceuticals, Inc.	-5.85%	-24.7%	-11.77%	17.09%	105.58%
Biontech Se	12.25%	24.31%	22.8%	-57.11%	240.97%
Alnylam Pharmaceuticals, Inc.	-5.5%	58.79%	40.79%	36.33%	111.58%
Vertex Pharmaceuticals Incorporated	-4.43%	-2.24%	15.61%	124.98%	113.34%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Collplant Biotechnologies Ltd	NA	NA	NA	0.0	-0.62	-0.34	NA	2.48
Regeneron Pharmaceuticals, Inc.	19.27	19.27	1.17	45.03	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.24	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Collplant Biotechnologies Ltd	Buy	$44.8M	-28.55%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$86.6B	105.58%	19.27	33.61%
Biontech Se	Buy	$28.0B	240.97%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	111.58%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$122.1B	113.34%	32.84	-4.51%

About Collplant Biotechnologies

collplant is a regenerative medicine company focused on 3d bioprinting of tissues and organs, and on developing and commercializing tissue repair products for orthobiologics, and advanced wound care markets. our products are based on our rhcollagen (recombinant human collagen) that is produced with collplant’s proprietary plant based genetic engineering technology. our products address indications for diverse fields of organ and tissue repair, and are ushering in a new era in regenerative medicine. our flagship rhcollagen bioink product line is ideal for 3d bioprinting of tissues and organs, and our unique vergenix line of rhcollagen products includes a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. collplant is a public company listed on the tel aviv stock exchange and on nasdaq (clgn).

Organization	Collplant Biotechnologies
Employees	75
CEO	Mr. Yehiel Tal
Industry	Health Technology

Management People of Collplant Biotechnologies

Name	Title
Mr. Yehiel Tal	CEO & Director
Mr. Eran Rotem CPA	Deputy CEO & CFO
Mr. Oren Fahimipoor	Vice President of Operations
Dr. Elana Gazal	Vice President of Research & Development
Prof. Oded Shoseyov	Founder & Chief Scientist
Ms. Hadas Dreiher Horowitz	Vice President of Human Resources

Important FAQs about investing in Collplant Biotechnologies from India :

What is Collplant Biotechnologies share price today?

Collplant Biotechnologies (CLGN) share price today is $3.93.

Can Indians buy Collplant Biotechnologies shares?

Yes, Indians can invest in the Collplant Biotechnologies (CLGN) from India.

With INDmoney, you can buy Collplant Biotechnologies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Collplant Biotechnologies at zero transaction cost.

How can I buy Collplant Biotechnologies shares from India?

It is very easy to buy Collplant Biotechnologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Collplant Biotechnologies be purchased?

Yes, you can buy fractional shares of Collplant Biotechnologies with INDmoney app.

What are the documents required to start investing in Collplant Biotechnologies stocks?

To start investing in Collplant Biotechnologies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Collplant Biotechnologies

Today’s highest price of Collplant Biotechnologies (CLGN) is $4.10.

Today’s lowest price of Collplant Biotechnologies (CLGN) is $3.85.

What is today's market capitalisation of Collplant Biotechnologies

Today's market capitalisation of Collplant Biotechnologies CLGN is 44.8M

What is the 52 Week High and Low Range of Collplant Biotechnologies

52 Week High
$6.99
52 Week Low
$3.31

How much percentage Collplant Biotechnologies is down from its 52 Week High?

Collplant Biotechnologies (CLGN) share price is $3.93. It is down by 43.78% from its 52 Week High price of $6.99.

How much percentage Collplant Biotechnologies is up from its 52 Week low?

Collplant Biotechnologies (CLGN) share price is $3.93. It is up by 18.73% from its 52 Week Low price of $3.31.

What are the historical returns of Collplant Biotechnologies?

1 Month Returns
-10.88%
3 Months Returns
-21.4%
1 Year Returns
-20.93%
5 Years Returns
-28.55%

Who is the Chief Executive Officer (CEO) of Collplant Biotechnologies

Mr. Yehiel Tal is the current Chief Executive Officer (CEO) of Collplant Biotechnologies.

Discover More

Explore all